Bernard Christophe BARLAAM,Daniel Hillebrand O'DONOVAN,Samantha Jayne HUGHES,Thomas Andrew MOSS,Johannes Wilhelmus Maria NISSINK,James Stewart SCOTT,Bin YANG,Daniel Hillebrand ODONOVAN
申请号：
US15782904
公开号：
US20180111931A1
申请日:
2017.10.13
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The specification relates to compounds of Formula (I):and to pharmaceutically acceptable salts thereof, to processes and intermediates used for their preparation, to pharmaceutical compositions containing them and to their use in the treatment of cell proliferative disorders.
